Acetyldigitoxin
Acetyldigitoxin may decrease the cardiotoxic activities of Gemcitabine.
Ancestim
The risk or severity of cytotoxicity can be increased when Ancestim is combined with Gemcitabine.
Anhydrous Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Gemcitabine.
Advertisement
Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Gemcitabine.
Apalutamide
The serum concentration of Gemcitabine can be decreased when it is combined with Apalutamide.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Gemcitabine.
Advertisement
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Gemcitabine.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Gemcitabine.
Bevacizumab
Bevacizumab may increase the cardiotoxic activities of Gemcitabine.
Advertisement
Bevacizumab-Awwb
Bevacizumab may increase the cardiotoxic activities of Gemcitabine.
Bleomycin
The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bleomycin.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Gemcitabine.
Clozapine
The risk or severity of adverse effects can be increased when Gemcitabine is combined with Clozapine.
Cyclophosphamide
Cyclophosphamide may increase the cardiotoxic activities of Gemcitabine.
Cyclophosphamide Anhydrous
Cyclophosphamide may increase the cardiotoxic activities of Gemcitabine.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Gemcitabine.
Deslanoside
Deslanoside may decrease the cardiotoxic activities of Gemcitabine.
Digitoxin
Digitoxin may decrease the cardiotoxic activities of Gemcitabine.
Digoxin
Digoxin may decrease the cardiotoxic activities of Gemcitabine.
Dipyrone
The risk or severity of myelosuppression can be increased when Metamizole is combined with Gemcitabine.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Gemcitabine.
DOCETAXEL ANHYDROUS
The risk or severity of adverse effects can be increased when Docetaxel is combined with Gemcitabine.
Fingolimod
Gemcitabine may increase the immunosuppressive activities of Fingolimod.
Fluorouracil
The serum concentration of Fluorouracil can be increased when it is combined with Gemcitabine.
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Gemcitabine.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Gemcitabine.
Isavuconazole
The serum concentration of Gemcitabine can be increased when it is combined with Isavuconazole.
Leflunomide
The risk or severity of adverse effects can be increased when Gemcitabine is combined with Leflunomide.
Lumacaftor
The serum concentration of Gemcitabine can be decreased when it is combined with Lumacaftor.
Natalizumab
The risk or severity of adverse effects can be increased when Gemcitabine is combined with Natalizumab.
Ocrelizumab
Ocrelizumab may increase the immunosuppressive activities of Gemcitabine.
Ouabain
Ouabain may decrease the cardiotoxic activities of Gemcitabine.
Ovine Digoxin Immune Fab
Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Gemcitabine.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Gemcitabine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gemcitabine.
Proscillaridin
Proscillaridin may decrease the cardiotoxic activities of Gemcitabine.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Gemcitabine.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Gemcitabine.
Ranolazine
The serum concentration of Gemcitabine can be increased when it is combined with Ranolazine.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Gemcitabine.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Gemcitabine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Gemcitabine.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Gemcitabine.
sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Gemcitabine.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Gemcitabine.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Gemcitabine.
Tofacitinib
Gemcitabine may increase the immunosuppressive activities of Tofacitinib.
Trastuzumab
Trastuzumab may increase the cardiotoxic activities of Gemcitabine.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Gemcitabine.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Gemcitabine.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Gemcitabine.
Vemurafenib
The serum concentration of Gemcitabine can be increased when it is combined with Vemurafenib.
Warfarin
Gemcitabine may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Gemcitabine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Gemcitabine.
